“Pharmacological Properties of Fructooligosaccharides Modulates the Lipopolysaccharide-Induced Gastrointestinal Tract Inflammation in Mice” (2023) Asian Journal of Pharmaceutics (AJP), 17(2). doi:10.22377/ajp.v17i2.4855.